These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 19215786)

  • 21. Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness.
    Cicek MS; Nock NL; Li L; Conti DV; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1331-6. PubMed ID: 15298954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
    Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
    Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The V89L polymorphism in the 5-alpha-reductase type 2 gene and risk of breast cancer.
    van Gils CH; Onland-Moret NC; Roest M; van Noord PA; Peeters PH
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1194-9. PubMed ID: 14652280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
    Ewart-Toland A; Chan JM; Yuan J; Balmain A; Ma J
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):759-64. PubMed ID: 15159307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Polymorphism of metabolic gene and genetic susceptibility to prostate cancer].
    Guan TY; Li M; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1467-70. PubMed ID: 16318816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men.
    Schatzl G; Madersbacher S; Gsur A; Preyer M; Haidinger G; Haitel A; Vutuc C; Micksche M; Marberger M
    Prostate; 2002 Jul; 52(2):130-8. PubMed ID: 12111704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Case-control study of the genes of receptors of the androgens of vitamin-D and of 5-alphareductase in a population of Afro-Caribbean population with prostate cancer].
    Veronique-Baudin J; Dieye M; Kouyoumdjian JC; Vacheron F; Draganescu C; Azaloux H
    Prog Urol; 2006 Jun; 16(3):303-10. PubMed ID: 16821341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
    Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis.
    Shibata A; Garcia MI; Cheng I; Stamey TA; McNeal JE; Brooks JD; Henderson S; Yemoto CE; Peehl DM
    Prostate; 2002 Sep; 52(4):269-78. PubMed ID: 12210487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer.
    Huang SP; Wu WJ; Chang WS; Wu MT; Chen YY; Chen YJ; Yu CC; Wu TT; Lee YH; Huang JK; Huang CH
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2217-24. PubMed ID: 15598783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPH.
    Roberts RO; Bergstralh EJ; Farmer SA; Jacobson DJ; McGree ME; Hebbring SJ; Cunningham JM; Anderson SA; Thibodeau SN; Lieber MM; Jacobsen SJ
    Prostate; 2005 Mar; 62(4):380-7. PubMed ID: 15389785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of three polymorphisms in the steroid-5-alpha-reductase, alpha polypeptide 2 gene (SRD5A2) and risk of prostate cancer.
    Li X; Huang Y; Fu X; Chen C; Zhang D; Yan L; Xie Y; Mao Y; Li Y
    Mutagenesis; 2011 May; 26(3):371-83. PubMed ID: 21177315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study.
    Severi G; Hayes VM; Padilla EJ; English DR; Southey MC; Sutherland RL; Hopper JL; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):610-2. PubMed ID: 17372260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
    Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
    Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and characterization of somatic steroid 5alpha-reductase (SRD5A2) mutations in human prostate cancer tissue.
    Makridakis N; Akalu A; Reichardt JK
    Oncogene; 2004 Sep; 23(44):7399-405. PubMed ID: 15326487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphism of the SRD5A2 gene and the risk of prostate cancer.
    Dušenka R; Tomaškin R; Kliment J; Dobrota D; Dušenková S; Vilčková M; Sivoňová MK
    Mol Med Rep; 2014 Dec; 10(6):3151-6. PubMed ID: 25310105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
    Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer.
    Tanaka Y; Sasaki M; Shiina H; Tokizane T; Deguchi M; Hirata H; Hinoda Y; Okayama N; Suehiro Y; Urakami S; Kawakami T; Kaneuchi M; Pookot D; Igawa M; Okuyama A; Ishii N; Dahiya R
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):238-44. PubMed ID: 16492910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TA repeat polymorphism of the 5alpha-reductase gene and breast cancer.
    Bharaj B; Scorilas A; Giai M; Diamandis EP
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):387-93. PubMed ID: 10794483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.
    Nam RK; Zhang WW; Klotz LH; Trachtenberg J; Jewett MA; Sweet J; Toi A; Teahan S; Venkateswaran V; Sugar L; Loblaw A; Siminovitch K; Narod SA
    Clin Cancer Res; 2006 Nov; 12(21):6452-8. PubMed ID: 17085659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.